U.S. markets open in 9 hours 1 minute

Nevro Corp. (NVRO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
152.14+0.92 (+0.61%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close151.22
Open151.80
Bid0.00 x 1800
Ask0.00 x 800
Day's Range150.49 - 153.45
52 Week Range108.69 - 188.14
Volume534,323
Avg. Volume397,485
Market Cap5.278B
Beta (5Y Monthly)0.99
PE Ratio (TTM)N/A
EPS (TTM)-2.47
Earnings DateApr 07, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est199.08
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Is NVRO Stock A Buy or Sell?
    Insider Monkey

    Is NVRO Stock A Buy or Sell?

    The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31st. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […]

  • Nevro to Present at BofA Securities 2021 Virtual Health Care Conference
    PR Newswire

    Nevro to Present at BofA Securities 2021 Virtual Health Care Conference

    Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 2:00 pm Eastern Time / 11:00 am Pacific Time.

  • Nevro to Report First Quarter 2021 Financial Results
    PR Newswire

    Nevro to Report First Quarter 2021 Financial Results

    Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021.